公开(公告)号：US20200246348A1

公开(公告)日：2020-08-06

申请号：US16851980

申请日：2020-04-17

Applicant: Supernus Pharmaceuticals, Inc.

Inventor： Jennifer DUGAN STOCKS ,  Christopher Evans ,  Seung Hwang ,  Susan M. Dallabrida

IPC: A61K31/5377 ,  G16H10/20 ,  G16H50/30 ,  G16H50/20

Abstract: The present disclosure relates to the treatment of impulsive aggression with molindone as an add-on therapy where patients are already receiving treatment for the underlying disease or disorder, e.g. attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism, Tourette's syndrome or post traumatic stress disorder (PTSD), using evidence-based impulsive aggression testing methodologies and systems.